{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT02032004",
      "OrgStudyIdInfo": {
        "OrgStudyId": "MSB-MPC-CHF001"
      },
      "Organization": {
        "OrgFullName": "Mesoblast, Ltd.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.",
      "OfficialTitle": "Double-blind, Randomized, Sham-procedure-controlled, Parallel-Group Efficacy and Safety Study of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) in Chronic Heart Failure Due to LV Systolic Dysfunction (Ischemic or Nonischemic) Dream HF-1",
      "Acronym": "DREAM HF-1"
    },
    "StatusModule": {
      "StatusVerifiedDate": "January 2022",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "February 14, 2014",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "May 29, 2020",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "May 29, 2020",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "January 8, 2014",
      "StudyFirstSubmitQCDate": "January 8, 2014",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "January 9, 2014",
        "StudyFirstPostDateType": "Estimate"
      },
      "DispFirstSubmitDate": "May 21, 2021",
      "DispFirstSubmitQCDate": "May 21, 2021",
      "DispFirstPostDateStruct": {
        "DispFirstPostDate": "May 25, 2021",
        "DispFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "January 5, 2022",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "January 10, 2022",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Mesoblast, Inc.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes"
    },
    "DescriptionModule": {
      "BriefSummary": "The primary objective of this study is to determine whether transendocardial delivery of allogeneic human bone marrow-derived mesenchymal precursor cells (MPCs [rexlemestrocel-L]) is effective in the treatment of chronic heart failure (HF) due to left ventricular (LV) systolic dysfunction.",
      "DetailedDescription": "The purpose of this study is to evaluate the efficacy and safety of a single transendocardial delivery in the cardiac catheterization laboratory of human bone marrow-derived allogeneic MPCs (rexlemestrocel-L) for improvement in clinical outcomes (heart failure major adverse cardiac events [HF-MACE]), preventing further adverse cardiac remodeling (left ventricular end systolic volume [LVESV] and left ventricular end-diastolic volume [LVEDV]), and increasing exercise capacity (six-minute walking test [6MWT]) in patients with chronic HF due to LV systolic dysfunction of either ischemic or nonischemic etiology who have received optimal medical/revascularization therapy."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Chronic Heart Failure"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Chronic Heart Failure",
          "CHF",
          "Left Ventricular Systolic Dysfunction",
          "Ischemic Heart Failure",
          "Nonischemic Heart Failure",
          "Stem Cells",
          "Allogeneic Mesenchymal Precursor Cells"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 3"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Triple",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Investigator",
              "Outcomes Assessor"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "566",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Allogeneic Mesenchymal Precursor Cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Participants randomly assigned to treatment will undergo a single index cardiac catheterization involving transendocardial delivery of rexlemestrocel-L into the myocardium at a cell injection center by an interventional cardiology team not involved with review or assessment of subsequent study results.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Allogeneic Mesenchymal Precursor Cells (MPCs)"
              ]
            }
          },
          {
            "ArmGroupLabel": "Control Treatment",
            "ArmGroupType": "Sham Comparator",
            "ArmGroupDescription": "Participants randomly assigned to control treatment will undergo a single cardiac catheterization involving a scripted sham cardiac mapping and cell delivery procedure at a cell injection center by an interventional cardiology team not involved with review or assessment of subsequent study results.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Sham Comparator"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Allogeneic Mesenchymal Precursor Cells (MPCs)",
            "InterventionDescription": "Rexlemestrocel-L consists of human bone marrow-derived allogeneic MPCs isolated from bone mononuclear cells with anti-STRO-3 antibodies, expanded ex vivo, and cryopreserved",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Allogeneic Mesenchymal Precursor Cells"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "MPCs",
                "rexlemestrocel-L"
              ]
            }
          },
          {
            "InterventionType": "Other",
            "InterventionName": "Sham Comparator",
            "InterventionDescription": "The sham procedure will be staged to script and will not include actual cardiac mapping or delivery of rexlemestrocel-L.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Control Treatment"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Time to recurrent non-fatal decompensated heart failure major adverse cardiac events (HF-MACE) that occur prior to the first terminal cardiac event (TCE).",
            "PrimaryOutcomeTimeFrame": "6 Month minimum"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Time-to-first terminal cardiac event (TCE)",
            "SecondaryOutcomeTimeFrame": "6 Month minimum"
          },
          {
            "SecondaryOutcomeMeasure": "Time-to-hospital admissions for non-fatal decompensated HF events",
            "SecondaryOutcomeTimeFrame": "6 Month minimum"
          },
          {
            "SecondaryOutcomeMeasure": "Time-to-urgent care outpatient HF visits",
            "SecondaryOutcomeTimeFrame": "6 Month minimum"
          },
          {
            "SecondaryOutcomeMeasure": "Time-to-successfully resuscitated cardiac death (RCD) events",
            "SecondaryOutcomeTimeFrame": "6 Month minimum"
          },
          {
            "SecondaryOutcomeMeasure": "Total length of in-hospital stay in intensive care unit for non-fatal decompensated HF events",
            "SecondaryOutcomeTimeFrame": "6 Month minimum"
          },
          {
            "SecondaryOutcomeMeasure": "Time-to-first HF-MACE (composite of hospital admissions for decompensated HF, urgent care outpatient HF visit, and successfully RCD events)",
            "SecondaryOutcomeTimeFrame": "6 Month minimum"
          },
          {
            "SecondaryOutcomeMeasure": "Time-to-first HF-MACE (composite of hospital admissions for decompensated HF, urgent care outpatient HF visit, successfully RCD events or TCE)",
            "SecondaryOutcomeTimeFrame": "6 Month minimum"
          },
          {
            "SecondaryOutcomeMeasure": "Time-to-cardiac death",
            "SecondaryOutcomeTimeFrame": "6 Month minimum"
          },
          {
            "SecondaryOutcomeMeasure": "Time-to-all-cause death",
            "SecondaryOutcomeTimeFrame": "6 Month minimum"
          },
          {
            "SecondaryOutcomeMeasure": "Time-to-first non-fatal MI (myocardial infarction), non-fatal CVA (cerebrovascular attack) or coronary artery revascularization",
            "SecondaryOutcomeTimeFrame": "6 Month minimum"
          },
          {
            "SecondaryOutcomeMeasure": "Left Ventricular (LV) remodeling in LVESV determined by 2-D echocardiography",
            "SecondaryOutcomeTimeFrame": "Screening, day 0 (post-procedure), months 3, 6, and 12, and every 12 months thereafter during study conduct (6 Month minimum)"
          },
          {
            "SecondaryOutcomeMeasure": "Correlations between baseline LVESV <=100 mL and LVESV >100 mL and clinical outcomes",
            "SecondaryOutcomeTimeFrame": "6 Month minimum"
          },
          {
            "SecondaryOutcomeMeasure": "Correlations between baseline LVESV <=100 mL and LVESV >100 mL and change in Month 6 to baseline LVESV and clinical outcomes",
            "SecondaryOutcomeTimeFrame": "6 Month minimum"
          },
          {
            "SecondaryOutcomeMeasure": "LV remodeling in LVEDV determined by 2-D echocardiography",
            "SecondaryOutcomeTimeFrame": "Screening, day 0 (post-procedure), months 3, 6, and 12, and every 12 months thereafter during study conduct (6 Month minimum)"
          },
          {
            "SecondaryOutcomeMeasure": "Overall Left Ventricular systolic performance as assessed by left ventricular ejection fraction (LVEF [radionuclide ventriculography {RVG} or echocardiogram])",
            "SecondaryOutcomeTimeFrame": "Screening, day 0 (post-procedure), months 3, 6, and 12, and every 12 months thereafter during study conduct (6 Month minimum)"
          },
          {
            "SecondaryOutcomeMeasure": "Functional exercise capacity as assessed by 6 Minute Walk Test",
            "SecondaryOutcomeTimeFrame": "Screening, months 3, 6, and 12, and every 12 months thereafter during study conduct (6 Month minimum)"
          },
          {
            "SecondaryOutcomeMeasure": "Functional status by New York Heart Association (NYHA) class",
            "SecondaryOutcomeTimeFrame": "Screening, months 3, 6, and 12, and every 12 months thereafter during study conduct (6 Month minimum)"
          },
          {
            "SecondaryOutcomeMeasure": "Quality of Life Measure - Minnesota Living With Heart Failure (MLHF) questionnaire",
            "SecondaryOutcomeTimeFrame": "Screening, months 3, 6, and 12, and every 6 months thereafter during study conduct (6 Month minimum)"
          },
          {
            "SecondaryOutcomeMeasure": "Quality of Life Measure - European Quality of Life (EuroQoL) 5-dimensional (EQ-5D) questionnaire",
            "SecondaryOutcomeTimeFrame": "Screening, months 3, 6, and 12, and every 6 months thereafter during study conduct (6 Month minimum)"
          },
          {
            "SecondaryOutcomeMeasure": "Safety as assessed by occurrence of adverse events related to the index cardiac catheterization on Day 0",
            "SecondaryOutcomeTimeFrame": "Day 0 through discharge from Day 0 hospitalization"
          },
          {
            "SecondaryOutcomeMeasure": "Safety as assessed by occurrence of treatment-emergent adverse events",
            "SecondaryOutcomeTimeFrame": "Screening through 6 Month minimum"
          },
          {
            "SecondaryOutcomeMeasure": "Safety as assessed by clinical laboratory tests (serum chemistry - ALT, AST, alkaline phosphate, GGT, LDH, BUN, creatinine, uric acid, total bilirubin - and hematology - hematocrit, hemoglobin, WBCs, eosinophils, ANC, platelet count)",
            "SecondaryOutcomeDescription": "ALT (alanine transaminase), AST (aspartate aminotransferase), GGT (gamma-glutamyl transferase), LDH (lactate dehydrogenase), BUN (blood urea nitrogen), WBCs (white blood cells), ANC (absolute neutrophil count)",
            "SecondaryOutcomeTimeFrame": "Screening, day 0 (post-procedure), day 10, months 1, 3, 6, and 12, and every 6 months thereafter during study conduct (6 Month minimum)"
          },
          {
            "SecondaryOutcomeMeasure": "Safety as assessed by urinalysis (blood, glucose, ketones, total protein)",
            "SecondaryOutcomeTimeFrame": "Screening, day 10, months 1, 3, 6, and 12, and every 6 months thereafter during study conduct (6 Month minimum)"
          },
          {
            "SecondaryOutcomeMeasure": "Safety as assessed by vital signs (pulse, systolic blood pressure [BP], diastolic BP)",
            "SecondaryOutcomeTimeFrame": "Screening, day 0 (pre and post-procedure), day 1, day 10, months 1, 3, 6, and 12, and every 6 months thereafter during study conduct (6 Month minimum)"
          },
          {
            "SecondaryOutcomeMeasure": "Safety as assessed by 12-lead electrocardiogram (ECG) findings - QT interval with Fridericia's correction (QTcF), heart rate-corrected QT interval (QTcB), QT, Q wave, R wave and S wave (QRS) complex, HR and T waves.",
            "SecondaryOutcomeTimeFrame": "Screening, day 0 (pre and post-procedure), day 1, day 10, months 1, 3, 6, and 12, and every 6 months thereafter during study conduct (6 Month minimum)"
          },
          {
            "SecondaryOutcomeMeasure": "Safety as assessed by telemetry monitoring findings (clinically significant arrhythmias)",
            "SecondaryOutcomeTimeFrame": "Day 0 through Day 0 overnight post-procedure"
          },
          {
            "SecondaryOutcomeMeasure": "Safety as assessed by rhythm analysis (specifically, ventricular arrhythmias) by interrogation of any implanted device capable of defibrillation",
            "SecondaryOutcomeTimeFrame": "Day 10, months 1, 3, 6, and 12, and every 6 months thereafter during study conduct (6 Month minimum)"
          },
          {
            "SecondaryOutcomeMeasure": "Safety as assessed by 24-hr Holter monitoring (HR, rate & duration of arrhythmias, a-fib average rate, supra- & ventricular ectopy singles/couplets/runs/totals, sustained & non-sustained ventricular tachycardia, longest pauses RR duration, total pauses)",
            "SecondaryOutcomeTimeFrame": "Screening, day 0 (post-procedure), day 10, months 1 and 3"
          },
          {
            "SecondaryOutcomeMeasure": "Safety as assessed by physical examination findings judged as clinically significant changes from baseline by the investigator or newly occurring abnormalities (including weight)",
            "SecondaryOutcomeTimeFrame": "Screening, month 12 and every 12 months thereafter until study conclusion (weight measured at screening, day 0 - pre and post-procedure, day 1, day 10, months 1, 3, 6 and 12 and every 6 months thereafter)"
          },
          {
            "SecondaryOutcomeMeasure": "Safety as assessed by important cardiovascular events from adjudicated data",
            "SecondaryOutcomeTimeFrame": "6 Month minimum"
          }
        ]
      },
      "OtherOutcomeList": {
        "OtherOutcome": [
          {
            "OtherOutcomeMeasure": "Pharmacodynamics Measures (N-terminal (NT)-pro hormone BNP [NT-proBNP] and high-sensitivity C-reactive protein [hs-CRP])",
            "OtherOutcomeTimeFrame": "Screening, months 3, 6, 12 and every 12 months thereafter until study conclusion"
          },
          {
            "OtherOutcomeMeasure": "Pharmacogenomics (PGx) Analysis",
            "OtherOutcomeTimeFrame": "Screening (only from those subjects who provide consent to participate in PGx sample collection)"
          },
          {
            "OtherOutcomeMeasure": "Immunogenicity Measures (panel reactive antibodies, donor specific antibody, if panel-reactive antibody (PRA) test is positive, antibodies against bovine and murine products)",
            "OtherOutcomeTimeFrame": "Screening, day 10, months 1, 3, 6, and 12"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nThe patient is 18 to 80 years of age, inclusive; both men and women will be enrolled.\nThe patient has a diagnosis of chronic HF of ischemic or nonischemic etiology for at least 6 months\nThe patient is on stable, optimally tolerated dosages of HF therapies including beta-blockers (approved for country-specific usage), angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs), and/or aldosterone antagonists, without change in dose for at least 1 month before study intervention\nThe patient is on a stable, outpatient, oral diuretic dosing regimen in which the patient remains clinically stable during screening.\nOther Criteria apply, please contact the investigator\n\nExclusion Criteria:\n\nThe patient has NYHA Functional Class I or Functional Class IV symptoms.\nOther Criteria apply, please contact the investigator",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "MaximumAge": "80 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Fred Grossman, DO",
            "OverallOfficialAffiliation": "Mesoblast, Ltd.",
            "OverallOfficialRole": "Study Director"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Mesoblast Investigational Site 10757 - Cardiology, P.C.",
            "LocationCity": "Birmingham",
            "LocationState": "Alabama",
            "LocationZip": "35211",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13262 - University of Alabama at Birmingham Hospital",
            "LocationCity": "Birmingham",
            "LocationState": "Alabama",
            "LocationZip": "35233",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10779 - Mercy Gilbert Medical Center",
            "LocationCity": "Gilbert",
            "LocationState": "Arizona",
            "LocationZip": "85297",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10786 - Cardiovascular Associates of Mesa",
            "LocationCity": "Mesa",
            "LocationState": "Arizona",
            "LocationZip": "85206",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10756 - Mayo Clinic",
            "LocationCity": "Phoenix",
            "LocationState": "Arizona",
            "LocationZip": "85054",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13023 - University of Arizona Medical Center",
            "LocationCity": "Tucson",
            "LocationState": "Arizona",
            "LocationZip": "85724",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10754 - University of California, San Diego",
            "LocationCity": "La Jolla",
            "LocationState": "California",
            "LocationZip": "92037",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10759 - Scripps Clinic",
            "LocationCity": "La Jolla",
            "LocationState": "California",
            "LocationZip": "92037",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13265 - University of California, Los Angeles",
            "LocationCity": "Los Angeles",
            "LocationState": "California",
            "LocationZip": "90045",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10775 - Cedars-Sinai Medical Care Foundation",
            "LocationCity": "Los Angeles",
            "LocationState": "California",
            "LocationZip": "90211",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10778 - Orange County Cardiology",
            "LocationCity": "Orange",
            "LocationState": "California",
            "LocationZip": "92868",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13031 - St. John's Regional Medical Center",
            "LocationCity": "Oxnard",
            "LocationState": "California",
            "LocationZip": "93030",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13275 - Stanford University Hospital",
            "LocationCity": "Stanford",
            "LocationState": "California",
            "LocationZip": "94305",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13267 - Bethesda Heart Hospital",
            "LocationCity": "Boynton Beach",
            "LocationState": "Florida",
            "LocationZip": "33435",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10780 - Morton Plant Hospital",
            "LocationCity": "Clearwater",
            "LocationState": "Florida",
            "LocationZip": "33756",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10760 - Shands Hospital, University of Florida",
            "LocationCity": "Gainesville",
            "LocationState": "Florida",
            "LocationZip": "32610",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13273 - University of Florida Health",
            "LocationCity": "Jacksonville",
            "LocationState": "Florida",
            "LocationZip": "32209",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10768 - University of Miami",
            "LocationCity": "Miami",
            "LocationState": "Florida",
            "LocationZip": "33215",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13280",
            "LocationCity": "Orlando",
            "LocationState": "Florida",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13264 - Florida Hospital Pepin Heart Institute",
            "LocationCity": "Tampa",
            "LocationState": "Florida",
            "LocationZip": "33613",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13027 - Emory University School of Medicine",
            "LocationCity": "Atlanta",
            "LocationState": "Georgia",
            "LocationZip": "30322",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10765 - Georgia Regents University",
            "LocationCity": "Augusta",
            "LocationState": "Georgia",
            "LocationZip": "30912",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10772 - University Cardiologist, Rush University Medical Center",
            "LocationCity": "Chicago",
            "LocationState": "Illinois",
            "LocationZip": "60612",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13030 - University of Iowa",
            "LocationCity": "Iowa City",
            "LocationState": "Iowa",
            "LocationZip": "52242",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10783 - Gill Heart Institute, University of Kentucky",
            "LocationCity": "Lexington",
            "LocationState": "Kentucky",
            "LocationZip": "40536",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13022 - University of Louisville",
            "LocationCity": "Louisville",
            "LocationState": "Kentucky",
            "LocationZip": "40202",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13266",
            "LocationCity": "New Orleans",
            "LocationState": "Louisiana",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10782",
            "LocationCity": "Boston",
            "LocationState": "Massachusetts",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10766 - Michigan Cardiovascular Institute",
            "LocationCity": "Saginaw",
            "LocationState": "Michigan",
            "LocationZip": "48602",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10762 - Minneapolis Heart Institute",
            "LocationCity": "Minneapolis",
            "LocationState": "Minnesota",
            "LocationZip": "55407",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10761 - Mayo Clinic",
            "LocationCity": "Rochester",
            "LocationState": "Minnesota",
            "LocationZip": "55905",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13281",
            "LocationCity": "Las Vegas",
            "LocationState": "Nevada",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13263 - RWJ Barnabas Heart Center",
            "LocationCity": "Newark",
            "LocationState": "New Jersey",
            "LocationZip": "07112",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10776 - Columbia University Medical Center",
            "LocationCity": "New York",
            "LocationState": "New York",
            "LocationZip": "10032",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13026 - Sanger Heart and Vascular Institute, Carolinas Healthcare System",
            "LocationCity": "Charlotte",
            "LocationState": "North Carolina",
            "LocationZip": "28203",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10781 - Duke University",
            "LocationCity": "Durham",
            "LocationState": "North Carolina",
            "LocationZip": "27710",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10758 - The Christ Hospital",
            "LocationCity": "Cincinnati",
            "LocationState": "Ohio",
            "LocationZip": "45219",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10770 - University of Cincinnati",
            "LocationCity": "Cincinnati",
            "LocationState": "Ohio",
            "LocationZip": "45267",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10773",
            "LocationCity": "Cleveland",
            "LocationState": "Ohio",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13278 - OhioHealth Research Institute",
            "LocationCity": "Columbus",
            "LocationState": "Ohio",
            "LocationZip": "43214",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10785 - Lehigh Valley Hospital",
            "LocationCity": "Allentown",
            "LocationState": "Pennsylvania",
            "LocationZip": "18103",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13261 - University of Pennsylvania",
            "LocationCity": "Philadelphia",
            "LocationState": "Pennsylvania",
            "LocationZip": "19104",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10767 - Temple University Hospital",
            "LocationCity": "Philadelphia",
            "LocationState": "Pennsylvania",
            "LocationZip": "19140",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13277",
            "LocationCity": "Philadelphia",
            "LocationState": "Pennsylvania",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10774 - University of Pittsburgh",
            "LocationCity": "Pittsburgh",
            "LocationState": "Pennsylvania",
            "LocationZip": "15213",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10777 - Stern Cardiovascular Foundation",
            "LocationCity": "Germantown",
            "LocationState": "Tennessee",
            "LocationZip": "38125",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13024 - Austin Heart, PLLC",
            "LocationCity": "Austin",
            "LocationState": "Texas",
            "LocationZip": "78756",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13274 - Soltero CV Research Center, Baylor Scott & White Research Institute",
            "LocationCity": "Dallas",
            "LocationState": "Texas",
            "LocationZip": "75226",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10755 - Texas Heart Institute",
            "LocationCity": "Houston",
            "LocationState": "Texas",
            "LocationZip": "77030",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13268 - Houston Methodist Hospital",
            "LocationCity": "Houston",
            "LocationState": "Texas",
            "LocationZip": "77030",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10763 - University Hospital",
            "LocationCity": "Salt Lake City",
            "LocationState": "Utah",
            "LocationZip": "84132",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10771 - Heart & Vascular Research, Swedish Medical Center",
            "LocationCity": "Seattle",
            "LocationState": "Washington",
            "LocationZip": "98122",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10764 - University of Wisconsin",
            "LocationCity": "Madison",
            "LocationState": "Wisconsin",
            "LocationZip": "53792",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10769 - Aurora Healthcare",
            "LocationCity": "Milwaukee",
            "LocationState": "Wisconsin",
            "LocationZip": "53215",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 13279",
            "LocationCity": "Milwaukee",
            "LocationState": "Wisconsin",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 10789 - Aspirus Research Institute",
            "LocationCity": "Wausau",
            "LocationState": "Wisconsin",
            "LocationZip": "54401",
            "LocationCountry": "United States"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 11027",
            "LocationCity": "Edmonton",
            "LocationState": "Alberta",
            "LocationCountry": "Canada"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 11024 - Victoria Heart Institute Foundation",
            "LocationCity": "Victoria",
            "LocationState": "British Columbia",
            "LocationZip": "V8R 4R2",
            "LocationCountry": "Canada"
          },
          {
            "LocationFacility": "Mesoblast Investigational Site 11025 - St. Michael's Hospital",
            "LocationCity": "Toronto",
            "LocationState": "Ontario",
            "LocationZip": "M5B 1W8",
            "LocationCountry": "Canada"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "31318648",
            "ReferenceType": "derived",
            "ReferenceCitation": "Borow KM, Yaroshinsky A, Greenberg B, Perin EC. Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure. Circ Res. 2019 Jul 19;125(3):265-281. doi: 10.1161/CIRCRESAHA.119.314951. Epub 2019 Jul 18. Review. Erratum in: Circ Res. 2019 Aug 16;125(5):e28."
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Yes"
    }
  },
  "ResultsSection": {
    "MoreInfoModule": {}
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022",
      "RemovedCountryList": {
        "RemovedCountry": [
          "Austria",
          "Belarus",
          "Bulgaria",
          "Finland",
          "France",
          "Germany",
          "Italy",
          "Latvia",
          "Lithuania",
          "Netherlands",
          "Poland",
          "Russian Federation",
          "Singapore",
          "Slovenia",
          "Spain",
          "Sweden",
          "Switzerland",
          "United Kingdom"
        ]
      }
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000006333",
            "ConditionMeshTerm": "Heart Failure"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000006331",
            "ConditionAncestorTerm": "Heart Diseases"
          },
          {
            "ConditionAncestorId": "D000002318",
            "ConditionAncestorTerm": "Cardiovascular Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M9695",
            "ConditionBrowseLeafName": "Ischemia",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8573",
            "ConditionBrowseLeafName": "Heart Failure",
            "ConditionBrowseLeafAsFound": "Heart Failure",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M26736",
            "ConditionBrowseLeafName": "Systolic Murmurs",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8571",
            "ConditionBrowseLeafName": "Heart Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M3377",
            "InterventionBrowseLeafName": "Antibodies",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M9336",
            "InterventionBrowseLeafName": "Immunoglobulins",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}